Activation or suppression of the immune system to treat disease
For the academic journal, see Immunotherapy (journal).
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Immunotherapy" – news · newspapers · books · scholar · JSTOR(April 2018)
This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Immunotherapy" – news · newspapers · books · scholar · JSTOR(April 2018) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Immunotherapy
The diagram above represents the process of chimeric antigen receptor T-cell therapy (CAR), this is a method of immunotherapy, which is a growing practice in the treatment of cancer. The final result should be a production of equipped T-cells that can recognize and fight the infected cancer cells in the body.
T-cells (represented by objects labeled as 't') are removed from the patient's blood.
Then in a lab setting the gene that encodes for the specific antigen receptors are incorporated into the T-cells.
Thus producing the CAR receptors (labeled as c) on the surface of the cells.
The newly modified T-cells are then further harvested and grown in the lab.
After a certain time period, the engineered T-cells are infused back into the patient.
MeSH
D007167
OPS-301 code
8-03
[edit on Wikidata]
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. Immunotherapy is under preliminary research for its potential to treat various forms of cancer.[1][2][3][4]
Cell-based immunotherapies are effective for some cancers.[5][6] Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells, and cytotoxic T lymphocytes work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells. Vaccine-induced immunity to COVID-19 relies mostly on an immunomodulatory T-cell response.[7]
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
^"Immunotherapy | Memorial Sloan Kettering Cancer Center". mskcc.org. Archived from the original on 2019-10-19. Retrieved 2017-07-27.
^Syn NL, Teng MW, Mok TS, Soo RA (December 2017). "De-novo and acquired resistance to immune checkpoint targeting". The Lancet. Oncology. 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.
^Conforti L (February 2012). "The ion channel network in T lymphocytes, a target for immunotherapy". Clinical Immunology. 142 (2): 105–106. doi:10.1016/j.clim.2011.11.009. PMID 22189042.
^Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA (August 2019). "Current Diagnosis and Management of Small-Cell Lung Cancer". Mayo Clinic Proceedings. 94 (8): 1599–1622. doi:10.1016/j.mayocp.2019.01.034. PMID 31378235.
^Riley RS, June CH, Langer R, Mitchell MJ (March 2019). "Delivery technologies for cancer immunotherapy". Nature Reviews. Drug Discovery. 18 (3): 175–196. doi:10.1038/s41573-018-0006-z. PMC 6410566. PMID 30622344.
^Li Y, McBride DW, Tang Y, Doycheva D, Zhang JH, Tang Z (September 2023). "Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells". Brain Hemorrhages. 4 (3): 147–153. doi:10.1016/j.hest.2023.02.003. ISSN 2589-238X.
^Geers D, Shamier MC, Bogers S, den Hartog G, Gommers L, Nieuwkoop NN, et al. (May 2021). "SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees". Science Immunology. 6 (59): eabj1750. doi:10.1126/sciimmunol.abj1750. PMC 9268159. PMID 34035118.
as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. Immunotherapy is under preliminary...
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies, such as insect bites...
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight...
treatment of allergies, including the prescription and delivery of allergy immunotherapy. The company was founded by Gene Kakaulin and Charles Jacoby in 2020...
these mites from the environment have not been found to be effective. Immunotherapy may be useful in those affected. Subcutaneous injections have better...
life-threatening pulmonary or brain oedema. Other drawbacks of IL-2 cancer immunotherapy are its short half-life in circulation and its ability to predominantly...
Active immunotherapy is a type of immunotherapy that aims to stimulate the host's immune system or a specific immune response to a disease or pathogen...
Stand Up to Cancer and the Cancer Research Institute to create the Immunotherapy Dream Team, uniting laboratory and clinical efforts that will lead to...
people to larger and larger amounts of allergen, known as allergen immunotherapy (AIT), is often effective. The allergen can be given as an injection...
reactions, injectable adrenaline (epinephrine) is recommended. Allergen immunotherapy, which gradually exposes people to larger and larger amounts of allergen...
biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops...
now marketed under the brand name Oncorine. With advances in cancer immunotherapy such as immune checkpoint inhibitors, increased attention has been given...
components or antigens to treat a disease or disorder is known as immunotherapy. Immunotherapy is most commonly used to treat allergies, autoimmune disorders...
epidermal layer". Therapies for metastatic melanoma include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such...
improving immune functionality and characteristics. In autologous cancer immunotherapy, T cells are extracted from the patient, genetically modified and cultured...
ERC-USA, ERC's US Subsidiary. Sitoiganap (EU)/Gliovac/ERC1671 is an immunotherapy vaccine that trains the body’s immune system to attack a Glioblastoma...
immunotherapy, targets spike protein of SARS-CoV-2 human bamlanivimab/etesevimab SARS-CoV-2 coronavirus causing the COVID-19 pandemic immunotherapy,...
immunoglobulins currently approved for use for infectious disease prophylaxis and immunotherapy, in the United States. Specific or not noted: hyperimmune globulin or...
and Institut Gustave Roussy in Paris shaped her initial interest in immunotherapy and inspired her move to Stanford to study dendritic cell-based vaccines...
a human IgG4 monoclonal antibody that blocks PD-1. It is a type of immunotherapy and works as a checkpoint inhibitor, blocking a signal that prevents...
prostate, and bladder cancers. Sharma studies the treatment of cancer with immunotherapy. Her doctoral work demonstrated that cells expressing thymus-leukemia...
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional...
Cellular adoptive immunotherapy is a type of immunotherapy. Immune cells such as T-cells are usually isolated from patients for expansion or engineering...
Global Information
